Background Supportive–expressive group therapy has been reported to prolong survival
among women with metastatic breast cancer. However, in recent studies, various psychosocial …

Purpose: Insulin, a member of a family of growth factors that includes insulin-like growth factor
(IGF)-I and IGF-II, exerts mitogenic effects on normal and malignant breast epithelial cells, …

Purpose Vitamin D has been linked to breast cancer risk, but prognostic effects are unknown.
Such effects are biologically plausible given the presence of vitamin D receptors in breast …

PURPOSE: Premenopausal women with breast cancer often enter a premature menopause
during initial treatment of their malignancy, with resulting loss of childbearing capacity, onset …

Biguanides have been developed for the treatment of hyperglycemia and type 2 diabetes.
Recently, metformin, the most widely prescribed biguanide, has emerged as a potential …

PURPOSE The purpose of this critical appraisal was to determine the prognostic factors that
influence survival in patients with nonmetastatic, high-grade osteosarcoma of the extremities…

PURPOSE: Weight gain is common during the first year after breast cancer diagnosis. In this
study, we examined clinical factors associated with body size at diagnosis and weight gain …

The anti-diabetic drug metformin is rapidly emerging as a potential anti-cancer agent.
Metformin, effective in treating type 2 diabetes and the insulin resistance syndromes, improves …

Methods We reviewed the literature regarding overweight and obesity and breast cancer
survival outcomes, overall and with regard to breast cancer subtypes, breast cancer therapies, …

Background: Insulin and insulin-like growth factor I (IGF-I) are important mitogens in vitro
and in vivo. It has been hypothesized that these factors may play an important role in the …